Company Search:
Advanced Search
Sponsored Links
Teva Pharmaceutical Industries Limited Company Snapshot
Teva Pharmaceutical Industries Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Teva Pharmaceutical Industries Limited with three other pharmaceutical manufacturers in Middle East: ndustries Co SAE of EGYPT (2019 sales of 3.41 billion Egyptian Pounds [US$217.83 million] of which 100% was Pharmaceutical), Taro Pharmaceutical Industries Ltd (2.44 billion Israel Shekels [US$743.36 million] of which 100% was Pharmaceutical Indust), and GlaxoSmithKline SAE which is based in EGYPT (1.70 billion Egyptian Pounds [US$108.82 million] of which 81% was Medical Sector).

Sales Analysis. Teva Pharmaceutical Industries Limited reported sales of 60.01 billion Israel Shekels (US$18.25 billion) for the year ending December of 2019. This represents a decrease of 11.7% versus 2018, when the company's sales were 67.97 billion Israel Shekels. Contributing to the drop in overall sales was the 26.3% decline in International Markets, from 10.83 billion Israel Shekels to 7.98 billion Israel Shekels. There were also decreases in sales in North America (down 9.4% to 30.36 billion Israel Shekels) and Europe (down 8.9% to 17.04 billion Israel Shekels) and Other (down 5.9% to 4.63 billion Israel Shekels) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Teva Pharmaceutical Industries Limited
  Stock Performance Chart for Teva Pharmaceutical Industries Limited
  Stock Data: Recent Stock Performance:
  Current Price (11/30/2020): 32.00
(Figures in Israel Shekels)
1 Week -1.5%   13 Weeks 4.6%  
4 Weeks -0.2%   52 Weeks -11.4%  
Teva Pharmaceutical Industries Limited Key Data:
  Ticker: TEVA Country: Israel
  Exchanges: TEL Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 60,010,656,420
(Year Ending Jan 2020).
Employees: 40,039
  Currency: Israel Shekels Market Cap: 35,620,000,000
  Fiscal Yr Ends: December Shares Outstanding: 1,096,000,000
  Share Type: Ordinary Closely Held Shares: 6,583,566
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.